Published in Blood Weekly, January 27th, 2000
Aethlon Medical is a developer of medical devices that treat a wide range of medical conditions through extracorporeal therapies, with operations in La Jolla, California, and Buffalo, New York.
The acquired technology applies a blood filtration technique developed by Hemex Inc., a wholly-owned subsidiary of Aethlon Medical, in a novel combination of surface modification technology and synthetic DNA hybridization technology. By embedding both antibodies and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.